Addex Therapeutics Ltd Revenue per Employee (ADXN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Addex Therapeutics Ltd  (NASDAQ: ADXN)
 

Addex Therapeutics Ltd's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Addex Therapeutics Ltd's Revenue per employee fell on a trailing twelve month basis to $ 1,763, below the company average number of $75,127.
Within the Healthcare sector Employees of 578 other companies have achieved higher revenue per employee. While Addex Therapeutics Ltd's total ranking has deteriorated compared to the previous quarter from 0 to 3961. Addex Therapeutics Ltd has 17 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADXN Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change -93.47 % - - - -71.54 %
Sales per Employee (TTM) $ 1,763 27,003 27,003 34,499 34,499
ADXN's Total Ranking # 3961 # 0 # # #
Seq. Revenue Change - - - - -

ADXN Company Profile >> Back to ADXN Efficiency Comparisons >> Compare ADXN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 219
Healthcare Sector # 579
Overall Market # 3961

Revenue per Employee Statistics
High Average Low
$ 171,548 $ 75,127 $ 1,763
(Dec 31 2021)   (Dec 31 2025)



Financial Statements
Addex Therapeutics Ltd's Revenue MRQ $ 0 Millions Visit ADXN's Income Statement
Addex Therapeutics Ltd's Revenues TTM $ 0 Millions Visit ADXN's aggregate revenue growth
What are ADXN's Sales? Visit ADXN's Sales by Segment




Other Ratios
Addex Therapeutics Ltd's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ADXN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ADXN's Competitors
Revenue per Employee for ADXN's Suppliers
Revenue per Employee for ADXN's Customers

You may also want to know
ADXN's Sales Growth Rates ADXN's Pe Price to earnings ratio ADXN's Receivables Turnover Ratio ADXN's Stock Quote
ADXN's Net Income Growth Rates ADXN's Ps Price to Sales ratio ADXN's Sales per Employee ADXN's Asset Turnover Ratio
ADXN's Net Margin ADXN's Pb Price to Book ratio ADXN's Financial Strength Ratios ADXN's Dividend Payout Ratio
Date modified: 2026-07-07T08:57:28+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Ainos Inc   3,028.22 $ 0.124  Million 41 
Clene Inc   2,531.65 $ 0.200  Million 79 
Prf Technologies Ltd   2,428.57 $ 0.017  Million 7 
Addex Therapeutics Ltd  1,763.06 $ 0.030  Million 17 
Pavmed Inc   1,731.71 $ 0.071  Million 41 
Hcw Biologics Inc   1,546.14 $ 0.054  Million 35 
Sera Prognostics Inc   1,125.00 $ 0.081  Million 72 
Kazia Therapeutics Limited  893.62 $ 0.042  Million 47 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.